TOP OF MIND: What directors are thinking
By Directors and Boards

Stacey Hallerman

Director, MedMen

As the axiom goes, serving as a director is a part-time job with full-time responsibilities. That principle is particularly applicable to directors of newly public companies. And it’s even more relevant for directors of companies in the fast-developing cannabis industry.

On the heels of several states legalizing the sale of cannabis in recent years, a thriving yet complex new industry has emerged. Investors’ interest is mounting but so, too, is their collective focus on cannabis companies able to demonstrate credibility in an emerging space with an evolving regulatory landscape. 

Against that backdrop, cannabis companies with boards that boast strong corporate governance practices and the diverse skills necessary to oversee dynamic operations in a complex operating environment give investors comfort and added reason to invest.

MedMen is a case in point. Since going public, the leading U.S. cannabis company has focused on building a board with governance expertise and wide-ranging skill sets. Its determination to get things right on these fronts played a big role in my decision to join MedMen’s board. The company strives to implement best practices across every aspect of its operations. The board is in its early days, but MedMen is committed to ensuring its directors amplify this company rule.

As a director of MedMen, I am one of eight board members, five of whom are independent. Collectively, our board has expertise in cannabis, consumer goods, luxury brands, retail, capital markets, legal, finance and tax, among others. We are tasked to understand the cannabis industry, and to both learn and address what matters most to our investors and other stakeholders.

 In the cannabis sector, directors must proactively seek out the information they need to fully understand the changing landscape and the competitive dynamics that impact the companies they govern. They also must partner closely with MedMen’s management team to ensure that the company’s strategic plans are aligned with the goal of creating long-term value for shareholders.  In these ways, a board can prove a genuine asset that complements the strategic planning of management, creating a competitive advantage.

Stacey Hallerman was vice president, chief legal counsel and corporate secretary at Richemont North America, part of the global luxury conglomarate that owns iconic brands such as Cartier, Chloe, Van Cleef & Arpels and Montblanc. She was also senior corporate counsel at Pfizer.

 


Issue: 
2018 Third Quarter

Other related articles

  • Sense of Purpose
    Published October 15, 2019
    By Robert H. Rock
    On November 20 and 21 Directors amp Boards is convening a select group of top public company board members institutional shareholders proxy advisors judicial and governmental representatives and corpo ...
  • What Directors are Thinking: Raj L. Gupta, DIRECTOR, Arconic Inc. and Dupont
    Published October 15, 2019
    By Directors and Boards
    Chairman of Avantor Inc and AptivFor over two decades I have served on several public and private company boards spanning various industries and sizes I have developed a strong conviction that boards ...
  • Indemnification Holes After a Company is Sold
    Published October 14, 2019
    By Doug Raymond
    Can a buyer cancel insurance or amend bylaws after a saleA good directors amp officers insurance policy frequently is the first and best line of defense But what happens to these layered protections w ...
  • Compensation Impacts Culture
    Published October 14, 2019
    By Katherine Barrall and Kathryn Neel
    Time to take stock of executive pay and perks programsLeadership and tone at the top are obvious corporate culture influencers What might be less obvious is how decisions on compensation structure sha ...